Statements of Changes in Stockholders' Equity (USD $)	Total	Common Stock [Member]	Additional Paid-in Capital [Member]	Retained Earnings [Member]
Balance at Dec. 31, 2012	$ 1,364,000	$ 218,000	$ 19,490,000	$ (18,344,000)
Balance (in shares) at Dec. 31, 2012		21,833,003
Shares issued in connection with consulting agreement	86,000	3,000	83,000
Shares issued in connection with consulting agreement (in shares)		333,333
Shares issued in connection with Series A Debenture extension	102,000	8,000	94,000
Shares issued in connection with Series A Debenture extension (in shares)		793,486
Warrants issued in connection with Imperium line of credit	299,000		299,000
Warrants issued in connection with Series A Debenture extension	121,000		121,000
Share based payment expense	154,000		154,000
Net loss	(788,000)			(788,000)
Balance at Dec. 31, 2013	1,338,000	229,000	20,241,000	(19,132,000)
Balance (in shares) at Dec. 31, 2013		22,959,822
Shares issued in connection with consulting agreement	25,000	2,000	23,000
Shares issued in connection with consulting agreement (in shares)		208,333
Shares issued in connection with Series A Debenture forbearance	7,000	1,000	6,000
Shares issued in connection with Series A Debenture forbearance (in shares)		58,575
Shares issued in connection with Landmark consulting agreement extension	50,000	4,000	46,000
Shares issued in connection with Landmark consulting agreement extension (in shares)		421,585
Share based payment expense	40,000		40,000
Net loss	(490,000)			(490,000)
Balance at Dec. 31, 2014	$ 970,000	$ 236,000	$ 20,356,000	$ (19,622,000)
Balance (in shares) at Dec. 31, 2014		23,648,315